Literature DB >> 12887466

Screening for prostate cancer: have you had your cholesterol measured?

P Boyle1.   

Abstract

Screening for prostate cancer has become one of the most common topics of conversation at urological oncology meetings. Most people have a bias as to whether there should or should not be a national screening programme. Unfortunately there are many unanswered questions, which may or may not be possible to answer definitively. In a balanced and scholarly review of the subject, Professor Peter Boyle indicates several flaws in the agreement for screening, but feels that PSA testing will continue unabated. The authors from the University of Stellenbosch review the plentiful literature relating to testicular torsion and functional recovery. They also review the mechanism of injury and the effect on the contralateral testis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12887466     DOI: 10.1046/j.1464-410x.2003.04306.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  3 in total

Review 1.  Prostate cancer epidemiology in the United States.

Authors:  Otis W Brawley
Journal:  World J Urol       Date:  2012-04-05       Impact factor: 4.226

2.  Trends in prostate cancer in the United States.

Authors:  Otis W Brawley
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

Review 3.  Prostate-specific antigen and detection of prostate cancer: What have we learned and what should we recommend for screening?

Authors:  Christopher L Amling
Journal:  Curr Treat Options Oncol       Date:  2006-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.